Arcellx (ACLX) Interest Coverage Ratio (2022 - 2025)
Arcellx (ACLX) recorded quarterly Interest Coverage Ratio of 19787.75 in Q4 2025, down 244.64% quarter-over-quarter from 5741.5 in Q1 2025, and down 160.6% on a YoY basis from 32652.91 in Q4 2024.
Arcellx (ACLX) Interest Coverage Ratio (2022 - 2025) Analysis & Trends
Arcellx's Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 19787.75 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio fell 160.6% year-over-year to 19787.75; the TTM figure through Sep 2025 stood at 12765.89 (down 36678.72% YoY), while the FY2024 annual figure was 133.56, down 470.93% from the prior year.
- Interest Coverage Ratio was 19787.75 for Q4 2025 at Arcellx, down from 5741.5 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 15.35 in Q4 2023 to a low of 19787.75 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 3628.14 across 4 years, with a median of 133.26 in 2024.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio soared 142.83% in 2023, then plunged 49559.97% in 2024.
- A 4-year view of Interest Coverage Ratio shows it stood at 35.85 in 2022, then jumped by 142.83% to 15.35 in 2023, then slumped by 49559.97% to 7593.14 in 2024, then tumbled by 160.6% to 19787.75 in 2025.
- The last three Interest Coverage Ratio figures came in at 19787.75 (Q4 2025), 5741.5 (Q1 2025), and 7593.14 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -19,787.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19,787.75 |
| Mar 31, 2025 | -5,741.50 |
| Dec 31, 2024 | -7,593.14 |
| Sep 30, 2024 | -294.88 |
| Jun 30, 2024 | -109.01 |
| Mar 31, 2024 | -26.89 |
| Dec 31, 2023 | 15.35 |
| Sep 30, 2023 | -46.78 |
| Jun 30, 2023 | -33.59 |
| Mar 31, 2023 | -29.69 |
| Dec 31, 2022 | -35.85 |
| Sep 30, 2022 | -157.51 |
| Jun 30, 2022 | -10,430.00 |
| Mar 31, 2022 | -6,522.75 |